VI
SRRA

Versor Investments’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Versor Investments’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,579,751
Closed -$86.9M – 1001
2022
Q2 		$86.9M Buy
+1,579,751
New +$82.9M 3.33% 11

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Versor Investments's SRRA Position: Q3 2022 in Review

Versor Investments sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 1,579,751 shares — an estimated $86.9M sold.

Versor Investments first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $86.9M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Versor Investments reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Versor Investments sold 1,579,751 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $86.9M.
  • Versor Investments first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Versor Investments's Sierra Oncology, Inc. Common Stock position peaked at $86.9M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Versor Investments's 13F filing for Q3 2022, filed 25 Oct 2022.